International research ethics.
This article provides a critical overview of the most important issues pertaining to the ongoing debate on international research ethics. It critically describes three problems of continuing concern: 1) the question of whether the distinction between therapeutic and non-therapeutic research should be upheld; 2) the questions of whether currently demanded best proven diagnostic and therapeutic methods of treatment for all research subjects is feasible both in developed and in developing countries, and whether it should be upheld; 3) the questions of who owns international research ethics guidelines and regulatory frameworks and, how decisions about changes to such international guidelines can possibly be achieved, given that it seems to be the case that genuine disagreement about issues of content is possible and likely.
Schuklenk
U
U
University of the Witwatersrand, Imperial College, London.
Ashcroft
R
R
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D019049:Developed Countries; D003906:Developing Countries; D032984:Ethics, Research; D017408:Guidelines as Topic; D006381:Helsinki Declaration; D006805:Human Experimentation; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D038622:Internationality; D033281:Nontherapeutic Human Experimentation; D010919:Placebos; D012107:Research Design; D036302:Therapeutic Human Experimentation
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D010919:Placebos